Pfizer seeks approval for oral COVID-19 pill in Japan

Economy Society

Pfizer Japan Inc. said Friday it has applied to the Japanese health ministry for approval of its COVID-19 pill which, if granted, would make it the second oral drug for mild coronavirus cases available in the country. The new drug application for Paxlovid, a combination of two antiviral drugs nirmatrelvir and ritonavir, comes at a time when Japan is battling its sixth surge of COVID-19 cases amid a spread of the Omicron variant, with Japan already agreeing to procure enough of the drug for 2 million people. Prime Minister Fumio Kishida said earlier in the week a final agreement with the Japane...

Kyodo News

Kyodo News Society